Heart devices technologies major Abiomed Inc. (NASDAQ:ABMD) reported fourth quarter fiscal 2012 adjusted (excluding one-time items except stock-based compensation expenses) earnings per share of 7 cents, beating the Zacks Consensus Estimate of 6 cents and surpassing the year-ago loss per share of 4 cents.
In the reported quarter, profit was $2.6 million (or 6 cents a share) versus a net loss of $1.8 million (or 5 cents a share) in the year-ago quarter.
For the fiscal year, adjusted earnings of 5 … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards